✦ LIBER ✦

OnabotulinumtoxinA 100U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

✍ Scribed by Rovner, E.S.

Book ID: 126875207
Publisher: Elsevier Science
Year: 2014
Weight: 55 KB
Volume: 2014
Category: Article
ISSN: 0084-4071
DOI: 10.1016/j.yuro.2014.03.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OnabotulinumtoxinA 100 U Significantly I

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

✍ Chapple, Christopher; Sievert, Karl-Dietrich; MacDiarmid, Scott; Khullar, Vik; R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 353 KB

741 Pivotal phase 3 study in overactive

741 Pivotal phase 3 study in overactive bladder (OAB) patients with urinary incontinence confirms onabotulinumtoxinA 100U significantly improves all OAB symptoms and patients' quality of life

✍ Chapple, C.; Sievert, K-D.; MacDiarmid, S.; Khullar, V.; Radziszewski, P.; Nardo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Re: OnabotulinumtoxinA Improves Health-R

Re: OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients with Urinary Incontinence due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial

✍ Wein, Alan J. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 129 KB

Efficacy and Safety of Onabotulinumtoxin

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

✍ Francisco Cruz; Sender Herschorn; Philip Aliotta; Mitchell Brin; Catherine Thomp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 749 KB

Efficacy and Safety of Onabotulinumtoxin

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double Blind, Placebo-Controlled Trial

✍ Rovner, E.S. 📂 Article 📅 2012 🏛 Elsevier Science ⚖ 47 KB

OnabotulinumtoxinA for the Treatment of

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

✍ Nitti, Victor W.; Dmochowski, Roger; Herschorn, Sender; Sand, Peter; Thompson, C 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 401 KB